Jack F. Wetzels

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 267 publications

SEISMIC: A multi-stakeholder summit addressing access issues in diagnosis and treatment of C3G nephropathy and IC-MPGN.

SEISMIC: A multi-stakeholder summit addressing access issues in diagnosis and treatment of C3G nephropathy and IC-MPGN.

Journal: Kidney international

Published: April 06, 2026

Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significance.

Executive summary of the European consensus report on the diagnosis and treatment of monoclonal gammopathy of renal significance.

Journal: Clinical kidney journal

Published: January 28, 2026

Biopsy Morphometrics as Predictors of Treatment Response in Primary Nephrotic Syndrome.

Biopsy Morphometrics as Predictors of Treatment Response in Primary Nephrotic Syndrome.

Journal: Kidney medicine

Published: January 09, 2026

Atypical Hemolytic Uremic Syndrome in Children and Adults With the Hot Spot C3 Gene Variant p.Arg161Trp.

Atypical Hemolytic Uremic Syndrome in Children and Adults With the Hot Spot C3 Gene Variant p.Arg161Trp.

Journal: Kidney international reports

Published: December 16, 2025

Confirmation of monotypic immunofluorescence staining by mass spectrometry in a case of proliferative glomerulonephritis.

Confirmation of monotypic immunofluorescence staining by mass spectrometry in a case of proliferative glomerulonephritis.

Journal: Histopathology

Published: December 16, 2025

Tailoring Eculizumab Treatment: Evaluation of Model-Informed Precision Dosing for Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic Syndrome.

Tailoring Eculizumab Treatment: Evaluation of Model-Informed Precision Dosing for Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic Syndrome.

Journal: Therapeutic drug monitoring

Published: October 01, 2025

Reassessing Rituximab in Membranous Nephropathy: Efficacy, Limitations, and the Path Ahead.

Reassessing Rituximab in Membranous Nephropathy: Efficacy, Limitations, and the Path Ahead.

Journal: Kidney international reports

Published: September 22, 2025

Disentangling disease heterogeneity in C3 glomerulopathies: a slippery road.

Disentangling disease heterogeneity in C3 glomerulopathies: a slippery road.

Journal: Kidney international

Published: September 16, 2025

Urinary Podocyte Loss is Associated With Treatment Response in Patients With Primary Nephrotic Syndrome.

Urinary Podocyte Loss is Associated With Treatment Response in Patients With Primary Nephrotic Syndrome.

Journal: Kidney international reports

Published: July 08, 2025

mRNA Sequencing to Identify Aberrant Splicing in X-linked Alport Syndrome.

mRNA Sequencing to Identify Aberrant Splicing in X-linked Alport Syndrome.

Journal: Kidney international reports

Published: June 25, 2025

Sensitivity of Enzyme-Linked Immunosorbent Assay in Monitoring Treatment Response in Phospholipase A2 Receptor -Associated Membranous Nephropathy.

Sensitivity of Enzyme-Linked Immunosorbent Assay in Monitoring Treatment Response in Phospholipase A2 Receptor -Associated Membranous Nephropathy.

Journal: Kidney international reports

Published: April 25, 2025

Is the Mayo prediction tool for MGRS ready for prime time?

Is the Mayo prediction tool for MGRS ready for prime time?

Journal: Kidney international

Published: April 13, 2025

Showing 1-12 of 267

Last Updated: 09/26/2026